1. Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
- Author
-
Reijnen, C., Gogou, E., Visser, N.C.M., Engerud, H., Ramjith, J., Putten, L.J.M. van der, Vijver, K. van der, Santacana, M., Bronsert, P., Bulten, J., Hirschfeld, M., Colas, E., Gil-Moreno, A., Reques, A., Mancebo, G., Krakstad, C., Trovik, J., Haldorsen, I.S., Huvila, J., Koskas, M., Weinberger, V., Bednarikova, M., Hausnerova, J., Wurff, A.A. van der, Matias-Guiu, X., Amant, F., Massuger, L.F.A.G., Snijders, M.P., Kusters-van de Velde, H.V.N., Lucas, P.J., Pijnenborg, J.M.A., Reijnen, C., Gogou, E., Visser, N.C.M., Engerud, H., Ramjith, J., Putten, L.J.M. van der, Vijver, K. van der, Santacana, M., Bronsert, P., Bulten, J., Hirschfeld, M., Colas, E., Gil-Moreno, A., Reques, A., Mancebo, G., Krakstad, C., Trovik, J., Haldorsen, I.S., Huvila, J., Koskas, M., Weinberger, V., Bednarikova, M., Hausnerova, J., Wurff, A.A. van der, Matias-Guiu, X., Amant, F., Massuger, L.F.A.G., Snijders, M.P., Kusters-van de Velde, H.V.N., Lucas, P.J., and Pijnenborg, J.M.A.
- Abstract
Contains fulltext : 220465.pdf (publisher's version ) (Open Access), BACKGROUND: Bayesian networks (BNs) are machine-learning-based computational models that visualize causal relationships and provide insight into the processes underlying disease progression, closely resembling clinical decision-making. Preoperative identification of patients at risk for lymph node metastasis (LNM) is challenging in endometrial cancer, and although several biomarkers are related to LNM, none of them are incorporated in clinical practice. The aim of this study was to develop and externally validate a preoperative BN to predict LNM and outcome in endometrial cancer patients. METHODS AND FINDINGS: Within the European Network for Individualized Treatment of Endometrial Cancer (ENITEC), we performed a retrospective multicenter cohort study including 763 patients, median age 65 years (interquartile range [IQR] 58-71), surgically treated for endometrial cancer between February 1995 and August 2013 at one of the 10 participating European hospitals. A BN was developed using score-based machine learning in addition to expert knowledge. Our main outcome measures were LNM and 5-year disease-specific survival (DSS). Preoperative clinical, histopathological, and molecular biomarkers were included in the network. External validation was performed using 2 prospective study cohorts: the Molecular Markers in Treatment in Endometrial Cancer (MoMaTEC) study cohort, including 446 Norwegian patients, median age 64 years (IQR 59-74), treated between May 2001 and 2010; and the PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study cohort, including 384 Dutch patients, median age 66 years (IQR 60-73), treated between September 2011 and December 2013. A BN called ENDORISK (preoperative risk stratification in endometrial cancer) was developed including the following predictors: preoperative tumor grade; immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PR), p53, and L1 cell adhesion molecule (L1CAM); cancer antigen 125 serum level; thrombocyte
- Published
- 2020